Waxes are available in various lyophilicity, and they can be used to regulate the release from multiunit-controlled release pellets. In this study, the application of saturated polyglycolysed glyceride (Gelucire® 50/02) and glycerol palmitostearate (Precirol® ATO5) as drug release regulators for propranolol pellets and the kinetics of release were investigated. Propranolol pellets containing 60% microcrystalline cellulose (Avicel® PH101) were prepared by using direct pelletization technique in a fluidized-bed rotary granulator (Glatt GPCG1). The pellets of 16:18 mesh size were collected and coated with the molten wax(es) at various ratios and thicknesses in a fluidized-bed top spray coater (Glatt GPCG1). The dissolution was determined using test method for Propranolol Extended Release Capsules USP 24 and was found to be very rapid with the uncoated pellets. The dissolution of coated pellet was decreased with the increases in Precirol ATO5 proportion and coating thickness. Plot of log % drug release vs. reciprocal of time showed a good linear relationship. The k value derived from the slope of the plot and designated as a “diffusive resistance constant” linearly increased with the coating level. The findings indicated that drug release could be adjusted by varying the ratio of Precirol® ATO5 to Gelucire® 50/02 as well as the thickness of the coat. 相似文献
The chemical degradation of N-(glutaryl-hyp-ala-ser-cyclohexylglycyl-gln-ser-leu)-doxorubicin (henceforth referred to as doxorubicin peptide conjugate 1) was studied in buffered aqueous solution. The pH-rate profile of degradation shows that the doxorubicin conjugate is most stable between pH 5 and 6. The dependence of log kobsd on pH in acidic medium is characteristic of specific acid-catalysis of the sugar hemiaminal of 1 (as in the case of doxorubicin). Isolation of degradates and structural determination shows that the degradation at lower pH values yields the water-insoluble aglycone doxorubicinone, supporting the mechanism of acid-catalyzed loss of the amino sugar. At pH higher than 5, a more complicated degradation pattern is observed, including the loss of the amino sugar and the aromatization of the saturated ring to give 7,8-dehydro-9,10-desacetyldoxorubicinone as one of the major products. Around the pH of maximum stability in solution, the rate of degradation of 1 is significantly greater than that for doxorubicin, which rules out the formulation of a room temperature solution product with a sufficiently long shelflife for market use. Design of a stable lyophilized formulation for sterile reconstitution based on the physicochemical properties of 1 is described. 相似文献
Microemulsions of water/isopropyl palmitate (IPP)/Aerosol OT (AOT)/1-butanol were developed as alternative formulations for topical delivery of clindamycin phosphate. Effect of AOT:1-butanol ratios on microemulsion region existence in the pseudoternary phase diagrams was investigated. The 2:1 AOT:1-butanol provided the largest microemulsion region. Five microemulsions of 1% w/w clindamycin phosphate were prepared and characterized. The permeation through human epidermis of the microemulsions was evaluated and compared with the 70% isopropanol solution using modified Franz diffusion cells. The drug permeation from all microemulsions was found to be significantly greater than that from the solution, indicating the enhancement of the skin permeation by the microemulsions. Within the same microemulsion type, the drug permeation increased with increasing the amount of AOT:1-butanol. The drug permeation from oil-in-water (o/w) microemulsions was relatively higher than that from water-in-oil (w/o) microemulsions. In addition, all microemulsions were stable for at least three months at 30 ± 1°C. 相似文献
Polylactide (PLA) blend films with poly(butylenes adipate-co-terephthalate) (PBAT) and a nucleating agent were prepared by the melt compounding technique. Thermal stability of the PLA decreased with added nucleating agent; in contrast, the decomposition temperature increased with the presence of PBAT. In addition, the differential scanning calorimetry thermograms demonstrated that the heterogeneous nucleation and cold crystallisation processes of the PLA blend films were accelerated.
The influence of the type and level of the nucleating agent and the presence of PBAT on the tensile properties, impact resistance, thermal stability and non-isothermal crystallisation behaviours of the PLA blend films were investigated. Both the PLA/nucleating agents and the PLA/PBAT/nucleating agent blends showed significant effects from the changes in the nucleation process on their tensile properties, impact toughness and thermal behaviour. Furthermore, the impact energy that the PLA blends absorbed during the entire impact tension test was obviously enhanced by the increased content of the nucleating agent. 相似文献
Three methacrylate-based copolymers [i.e., poly(methacrylic acid-co-methyl methacrylate) (E-L100), poly(ethyl acrylate-co-methyl
methacrylate-co-trimethyl-ammonioethyl methacrylate chloride) (E-RLPO), and poly(butyl methacrylate-co-(2-dimethylaminoethyl)
methacrylate-co-methyl methacrylate) (E-EPO)] were successfully electrospun into fibers, using ethanol (EtOH) as the spinning
solvent. However, electrospinning of these methacrylate-based copolymers and indomethacin (10% by weight of the copolymer)
was only successful when an equivolume of EtOH and ethylacetate (EA) was used as the co-solvent system. The drug-loaded as-spun
copolymeric fibers appeared to be flat, with the size ranging between 1.2 and 2.5 μm. At 24 h, the amount of the drug released
from these drug-loaded as-spun copolymer fibers was about 55%, 30%, and 18% for drug-loaded as-spun E-EPO, E-L100, and E-RLPO
fibers, respectively. 相似文献